Efficacy of phosphodiesterase‐4 inhibitors in juvenile Batten disease (CLN3)-Reference-Cited by-同舟云学术

Efficacy of phosphodiesterase‐4 inhibitors in juvenile Batten disease (CLN3)

Published:2016-11-23 Issue:6 Volume:80 Page:909-923
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Aldrich Amy¹,Bosch Megan E.²,Fallet Rachel¹,Odvody Jessica¹,Burkovetskaya Maria¹,Rama Rao Kakulavarapu V.¹,Cooper Jonathan D.³⁴,Drack Arlene V.⁵,Kielian Tammy¹

Affiliation:

1. Department of Pathology and MicrobiologyUniversity of Nebraska Medical CenterOmaha NE

2. Department of Pharmacology and Experimental NeuroscienceUniversity of Nebraska Medical CenterOmaha NE

3. Department of Basic & Clinical NeuroscienceKing's CollegeLondon United Kingdom

4. Los Angeles Biomedical Research Institute and David Geffen School of Medicine at UCLA, Harbor UCLA Medical CenterTorrance CA

5. Department of Ophthalmology and Visual SciencesUniversity of Iowa Carver College of MedicineIowa City IA

Funder

NIH National Institute of Neurological Disorders and Stroke

Batten Disease Support and Research Administration

University of Nebraska Medical Center

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.24815

Reference60 articles.

1. Isolation of a novel gene underlying batten disease, CLN3

2. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses

3. Clarifying lysosomal storage diseases

4. Thalami and corona radiata in juvenile NCL (CLN3): a voxel-based morphometric study

5. JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential;Cellular and Molecular Neurobiology;2023-04-19

2. Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease;Frontiers in Genetics;2023-03-24

3. Phosphodiesterase-4 Inhibitor Roflumilast-Mediated Protective Effect in Sepsis-Induced Late-Phase Event of Acute Kidney Injury: A Narrative Review;Pharmaceuticals;2022-07-20

4. Altered protein secretion in Batten disease;Disease Models & Mechanisms;2021-12-01

5. Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses;Molecules;2021-10-15